A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

• Status: Completed
• Trial end date: 2017-01-13
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare the efficacy and tolerability of Faslodex (fulvestrant) with Arimidex (anastrozole) in postmenopausal women with hormone receptor positive advanced breast cancer.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Anastrozole; Estradiol; Fulvestrant

Criteria

Inclusion Criteria:

• Confirmed hormone receptor positive advanced breast cancer, postmenopausal women

Exclusion Criteria:

• Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).